AI assistant
Sending…
AtriCure, Inc. — Director's Dealing 2016
Jan 11, 2016
31802_dirs_2016-01-11_5bebbf7a-ebd6-4810-a91b-0356574d21d4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AtriCure, Inc. (ATRC)
CIK: 0001323885
Period of Report: 2016-01-08
Reporting Person: Lanning Mark R (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-01-08 | Common Stock | M | 20000 | $11.06 | Acquired | 45000 | Direct |
| 2016-01-08 | Common Stock | M | 30000 | $9.37 | Acquired | 75000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-01-08 | Stock Option (right to buy) | $11.06 | M | 20000 | Disposed | 2016-02-08 | Common Stock (20000) | Direct |
| 2016-01-08 | Stock Option (right to buy) | $9.37 | M | 30000 | Disposed | 2016-04-06 | Common Stock (30000) | Direct |
Footnotes
F1: These options were granted on February 8, 2006 and are exercisable cumulatively at a rate of 25% per annum beginning one year from date of grant.
F2: These options were granted on April 6, 2006 and are exercisable cumulatively at a rate of 25% per annum beginning one year from date of grant.
More from AtriCure, Inc.
Regulatory Filings
2026
May 27
Declaration of Voting Results & Voting Rights Announcements
2026
May 19
Interim / Quarterly Report
2026
May 6
Report Publication Announcement
2026
May 5
Proxy Solicitation & Information Statement
2026
Apr 6
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3